We rank companies based on fund manager, research analyst and news sentiment
APDN stock icon

Applied DNA Sciences
APDN

$0.34
1.63%
 

About: Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Employees: 55

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

817% more call options, than puts

Call options by funds: $54.3K | Put options by funds: $5.92K

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding

Funds holding: 28 [Q3] → 28 (+0) [Q4]

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

7.52% less ownership

Funds ownership: 19.24% [Q3] → 11.72% (-7.52%) [Q4]

69% less capital invested

Capital invested by funds: $3.2M [Q3] → $989K (-$2.21M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$1.5
337%
upside
Avg. target
$1.75
410%
upside
High target
$2
483%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Yi Chen
337%upside
$1.5
Buy
Maintained
9 Feb 2024
HC Wainwright & Co.
Yi Chen
483%upside
$2
Buy
Maintained
8 Dec 2023

Financial journalist opinion